An international collaboration of researchers led by Bio21's Prof Karen Day, have developed a computational method to identify malaria parasites as they move around the world with their human hosts - key to measuring impact of elimination campaigns.
Leading malaria researcher Professor Leann Tilley and her team have uncovered the mechanism of how frontline antimalarial drug, artemisinin, works and are now working on a promising chemotherapy-based compound to treat patients.
Bio21's Dr Duffy believes the key to combating the public health challenge of malaria is to focus on those people who are most susceptible to severe malaria – young children – and focus on those malaria strains that are most likely to cause death.
A new genetic fingerprinting technique has for the first time shown the huge genetic diversity of the malaria parasite, one of nature’s most persistent and successful human pathogens.
Human red blood cells have remarkable abilities, allowing them to bend, extend and ‘squeeze’ through capillaries as they circulate through the blood stream.